The UB medical school faculty of 1861.
By ELLEN GOLDBAUM
They developed a sickle cell anemia test for newborn babies, found a way to make blood transfusions safer, and discovered that the body can, indeed, attack itself. They brought new scientific understanding to Buffalo, even when their ideas were initially ridiculed and later accepted as essential to human health. They fought and curbed devastating outbreaks in the city from typhoid, cholera and the 1918 influenza pandemic; today, they are fighting COVID-19.
They are the faculty, students and alumni of the Jacobs School of Medicine and Biomedical Sciences at UB, which this month begins its 175th anniversary year.
Founded on May 11, 1846, as the University of Buffalo, the institution existed originally as a private medical school.
As UB celebrates our 175th anniversary, we want to recognize the universitys origins as a medical school, share its compelling history and highlight the integral role that it has played, and continues to play, in the health and well-being of the Western New York community, says President Satish K. Tripathi.
Now, on the occasion of UBs 175th anniversary, the UB community is marking the anniversary by focusing on the universitys roots in medicine with a special commemorative issue of the Jacobs Schools alumni magazine, UB Medicine. It will be available online later this month.
Teaching physicians who take care of Buffalo
Michael E. Cain, vice president for health sciences and dean of the Jacobs School, says the magazine will help reveal to the wider community the critical role the medical school has played in the health and well-being of Western New Yorkers for 175 years.
Over the last 175 years, many physicians who have practiced in Western New York particularly in Buffalo and Erie County earned their medical degree at the University at Buffalo. For almost two centuries, we have consistently provided the physicians who take care of those of us who live in this community, Cain says.
One way to train future physicians to deliver the best clinical care is to have them be part of an institution that asks questions, challenges traditional paradigms, creates new knowledge and uses that new knowledge to advance the standard of care. The Jacobs School has consistently delivered this benefit throughout its 175 years of existence.
History of UB and medicine in WNY
The magazine opens with a fascinating 14-page timeline that is as much a history of medicine in Buffalo as it is a history of UB. The timeline begins at 1801, the date when Cyrenius Chapin, Buffalos first physician, settles in Western New York. It describes the burning of Buffalo by the British in 1813 and the rebuilding of what was then the village of Buffalo.
In 1846, the University of Buffalo was founded, consisting of the Medical Department, which remained the universitys sole unit throughout its first 40 years.
The timeline includes the establishment of some of Buffalos first hospitals, from the 1848 founding of Sisters of Charity Hospital, the regions first teaching hospital, and its role in caring for patients during the 1848 cholera outbreak, to the establishment in 1918 of a hospital now Erie County Medical Center for patients with tuberculosis on Grider Street. In 1858, Buffalo General Hospital was established, and in 1892, Childrens Hospital, now the John R. Oishei Childrens Hospital, was founded, becoming one of the nations first pediatric hospitals. The Veterans Administration hospital was founded in 1950.
The magazine also traces the critical fundraising that enabled the schools growth, starting with the first efforts by Charles Cary of the Class of 1875, whose work resulted in the schools new building at 24 High St. in 1893. In 1920, the school raised $5 million in 10 days from 24,000 donors.
In 1929, UBs second $5 million Endowment Fund Campaign closed on the same day as the stock market crash; thus, many pledges were never recovered due to financial hardship. Subsequent gifts are also noted, including those that led to additional buildings and expansion to what is today the South Campus. In 2011, nearly $50 million was left to the school by George M. Ellis Jr. of the Class of 1945, a family doctor in the rural Midwest who had saved for nearly 70 years. The gift came just as UB was making the decision to move the medical school downtown, which Cain said at the time made all the difference in our having the confidence to plan and move forward.
In 2015, Jeremy M. Jacobs, his wife, Margaret, and their family gave $30 million to the School of Medicine and Biomedical Sciences, a historic gift.In recognition of Jacobs tremendous service and philanthropy to the university, the UB medical school was named the Jacobs School of Medicine and Biomedical Sciences. The gift made the Jacobs family one of the universitys top benefactors, with gifts exceeding $50 million.
The timeline highlights the rich, intertwining medical histories of UB and the city of Buffalo including:
Other intriguing stories include that of Devillo W. Harrington, a Civil War soldier from the New England regiment, who was among members of his regiment transported to Buffalo General for care. Harrington was badly wounded and was left on the battlefield for three days before being evacuated. When he arrived in Buffalo, his case was considered hopeless until the UB interns who treated him decided to try a new type of surgical dressing on him, permanganate of potash. It was one of the first antiseptic surgical dressings. Not only did he recover, but he then attended UBs medical school, graduating in 1871 and becoming UBs first professor of genitourinary and venereal diseases. He later established the Harrington Lectureship, which has brought many outstanding physicians to UB throughout the schools history.
Mary Blair Moody, UB's first female graduate, received her medical degree in 1876.
Historic firsts among the schools graduates are also highlighted. In 1876, Mary Blair Moody was the first woman to graduate from the UB medical school. She was 40 and a mother of six when she graduated and went on to be named a fellow of the American Association for the Advancement of Science. She founded the Womens Educational and Industrial Union and supervised its Hygiene and Physical Education program.
Joseph Robert Love was the first Black graduate of the school in 1880. Born in the Bahamas, Love came to Buffalo, where he was ordained and did his medical training in preparation for medical missionary work in Haiti. He later moved to Jamaica, where he became involved in political work and in advocating for Black civil rights.
The timeline includes the recruiting of renowned surgeon Roswell Park to Buffalo from Chicago in 1883 and the eventual establishment in 1898 of the state-funded New York State Pathological Laboratory in Buffalo, housed at the UB medical school. It was the worlds first laboratory dedicated to the study of cancer, and Park was its first director. It changed names in 1911, and in 1946 was renamed for Park, becoming what is now Roswell Park Comprehensive Cancer Center.
Next quarter century
In August 2020, medical students participated in a socially distanced white coat ceremony during the COVID-19 pandemic. Photo: Sandra Kicman
As important as an understanding of UBs history in medicine is, Cain also wanted the magazine to focus on what the Jacobs School will do in the future. To that end, the issue includes one-page essays from many of the schools foremost faculty covering a wide range of topics, from health policy and health disparities and stem cells, to biomedical ethics, big data, team science and gender equity.
The issue also spotlights two current, historic moments that the world is experiencing: the COVID-19 pandemic and the racial reckoning that resulted from the murder of George Floyd last May. Articles delve into how the pandemic swiftly moved all medical teaching and research into an online endeavor and how that has impacted faculty, administrators and students. Graduating medical students suddenly found they werent traveling to residency interviews these, too, would be conducted online and UBs program directors had to quickly pivot as well.
UB medical residents, students and faculty joined with other health care workers for the White Coats for Black Lives protest in June 2020. Photo: Meredith Forrest Kulwicki
And while the world was responding to the devastation of COVID-19, the racial disparities the disease uncovered became all that much more apparent with Floyds murder. UBs medical students of color recount their experiences and reactions, starting with last years White Coats 4 Black Lives march, and how they are working with the medical school to foster change in the foundations of medical education.
Powerful patient stories
The voices that come through in the magazine cover an extraordinarily broad range of topics and opinions, but in the end, the true power of the Jacobs School is revealed in the quality of care it provides for its patients. The magazine includes several stories about the personal relationships and connections that patients and their families have established with Jacobs School researchers.
One tells the story of Hudson McKeefery, a little boy born in England with a rare mitochondrial disorder called FDXR. His physician found a scientific paper about the rare disorder and shared it with his parents; the author, one of very few in the world studying the disease, is Taosheng Huang, chief of the Division of Genetics in the Department of Pediatrics in the Jacobs School. Just before the pandemic, the McKeefery family flew to the U.S. from the United Kingdom, eager to find out as much as they could in order to help Hudson. Feeling heartened and hopeful by their connection with Huang, the McKeeferys donated $1 million to Huangs research effort at the Jacobs School to continue his work and to start patient registries for this rare disorder. Referring to Huang, the family noted: He is our main source of hope.
Other stories outline the philanthropic efforts of patients and their families that have been affected by Jacobs School faculty who are improving the lives of patients and families living with diseases ranging from multiple sclerosis and hemophilia to mental health issues and retinitis pigmentosa, which can cause blindness in children.
The magazine ends with a riveting black-and-white photo portfolio of Jacobs School faculty and students serving on the front lines of the pandemic. One of the last pieces in the magazine is a remembrance of Adeline Addie Fagan, Class of 2019, who died last year from complications of COVID-19. She had just begun her residency in obstetrics and gynecology. She was 28 years old.
The Jacobs School has also been a consistent voice for the public health in our community, Cain said in his Q&A in the magazine. We are an institution that advocates strongly for advancing public health measures at the local, state and federal levels of government, and through businesses and community outreach. We are champions of public health and as a school we have done, and will continue to do, everything we can to educate the public in a timely way about best practices in health and well-being.
- Home | Eli and Edythe Broad Center of Regeneration ... - June 24th, 2021
- California's Stem Cell Agency | California Institute for ... - June 24th, 2021
- Stem Cell & Regenerative Medicine Center University of ... - June 24th, 2021
- Special type of stem cell can reduce the amount of HIV virus - News-Medical.Net - June 24th, 2021
- Join the World Stem Cell Summit for a virtual conference ... - June 24th, 2021
- Novel Tafasitamab Combination Finds a Role in Second-line DLBCL Treatment - Targeted Oncology - June 24th, 2021
- Vita Therapeutics Raises $32 Million in Oversubscribed Series A Financing Led by Cambrian Biopharma to Advance the Development of Therapies to Treat... - June 24th, 2021
- Discrepancies Between Real-World Patterns of Care and Recommendations Based on Clinical Trials Exist in MCL - OncLive - June 24th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 24th, 2021
- World Sickle Cell Day: Symptoms and treatment options for Sickle Cell Disease - Times of India - June 24th, 2021
- More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities - Yahoo Finance - June 22nd, 2021
- New Therapeutic Drugs for Tendinitis Treatment Coming Down - GlobeNewswire - June 22nd, 2021
- Updates in the treatment of peripheral T-cell lymphomas | JEP - Dove Medical Press - June 22nd, 2021
- Stanford spinout Jasper Therapeutics inks deal with Aruvant to unlock new fix for sickle cell disease - San Francisco Business Times - San Francisco... - June 22nd, 2021
- Presence of certain stem cells linked to nongenetic resistance mechanisms of cancer cells - News-Medical.Net - June 20th, 2021
- Stem cell transplant boost for Tyrone man facing third battle with cancer as brother is a match - Belfast Telegraph - June 20th, 2021
- Theres always a way forward: Crunchtime for Mesoblast as legal threats loom - Sydney Morning Herald - June 20th, 2021
- Covid-19 treatment: Insurers silent on no cover for new therapies - BusinessLine - June 20th, 2021
- Cell therapies without cells? - Lexology - June 16th, 2021
- 'Impressive Results' With CAR T-cell in R/R Follicular Lymphoma - Medscape - June 16th, 2021
- ThermoGenesis : Cell Processing Technologies That Revolutionized the Cell and Gene Therapy Industry - Marketscreener.com - June 16th, 2021
- Good Response to COVID-19 Vaccine After HSCT and CAR T-cell Tx - Medscape - June 16th, 2021
- Citius Pharmaceuticals Expands Scientific Advisory Board with Addition of Dr. John Laffey, Expert in Stem Cell and Gene Therapies for ARDS -... - June 16th, 2021
- What Drives a Liver Cell To Be a Liver Cell? - Technology Networks - June 16th, 2021
- Dr. Martin on the Rationale to Evaluate Real-World Outcomes in MCL - OncLive - June 16th, 2021
- Bispecific Antibodies Wage a Two-Pronged Attack on Tumors - Curetoday.com - June 16th, 2021
- Maintenance With Rituximab for MCL Prolongs Time to Next Treatment - Cancer Network - June 16th, 2021
- Daratumumab Demonstrates Benefit to Overall Survival for Certain Patients with Multiple Myeloma - Pharmacy Times - June 16th, 2021
- Global Cell Isolation Market Research Report 2021: Rising Demand for Drugs, Vaccines and Other Related Products - Forecast to 2027 - PRNewswire - June 16th, 2021
- Regardless of Prior Anti-CD20 Therapy, Axi-Cel induces Durable Antitumor Activity in FL and MZL - Cancer Network - June 16th, 2021
- Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment - BioSpace - June 16th, 2021
- UCF 25th Among Public Universities in the Nation and 60th in the World for Producing Patents - UCF - June 16th, 2021
- Real-world analysis of patient characteristics, treatment outcomes, and healthcare resource utilization across Europe in patients with newly diagnosed... - June 14th, 2021
- San Diego Academy of Regenerative Therapies (SDARTs) 4th Global Conference Spotlights Regenerative Stem Cell Treatments for Hair Restoration -... - June 14th, 2021
- Omeros announces data for narsoplimab in pivotal trial for rare disease linked to stem cell transplantation - Seeking Alpha - June 14th, 2021
- Discrepancies Exist Between Actual Care and Trial-Based Recommendations in MCL - www.oncnursingnews.com/ - June 14th, 2021
- Debiopharm's CD37 Antibody Drug Conjugate Shows Promising Phase II Results for the Treatment of B-Cell Malignancies - BioSpace - June 14th, 2021
- Rituximab Maintenance Improves Time-to-Next Treatment and OS in Patients With Mantle Cell Lymphoma - Targeted Oncology - June 14th, 2021
- ViaCyte Announces Closing of $45 Million Financing to Advance Broadest Portfolio of Stem Cell-Derived Therapies for Type 1 Diabetes - BioSpace - June 13th, 2021
- Living Therapeutics Initiative Will Accelerate Development and Delivery of Revolutionary Treatments - UCSF News Services - June 13th, 2021
- Fundraising run will help MS sufferer fund far-reaching stem cell treatment in Mexico - Shetland Times Online - June 13th, 2021
- Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure - Business Wire - June 13th, 2021
- AI Predicts How Patients with Viral Infections, Including COVID-19, Will Fare - UC San Diego Health - June 13th, 2021
- Tisagenlecleucel Appears Effective in Babies With Advanced B-Cell Acute Lymphoblastic Leukemia - Cancer Therapy Advisor - June 13th, 2021
- Creative Medical Technology Holdings Identifies Synergy Between ImmCelz Regenerative Immunotherapy and Myeloid Suppressor Cells in Treatment of Type 1... - June 13th, 2021
- Stem Cells and Liver Cancer Laboratory Head Job at Walter and Eliza Hall Institute in Melbourne, Australia - The Conversation AU - June 13th, 2021
- Real-World Treatment Reveals Discrepancy Between Actual Care and Clinical Trial Recommendations in MCL - OncLive - June 13th, 2021
- CBMG Holdings' Novel Anti-CD20 CAR-T Cell Therapy Shows Promising Safety and Efficacy in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma Patients... - June 13th, 2021
- Naratuximab Emtansine With Rituximab Leads to Durable Responses in R/R DLBCL - Targeted Oncology - June 13th, 2021
- HSCT-Sparing, Chemotherapy-Free Treatment of Ph+ ALL With Ponatinib/Blinatumomab Leads to 100% CR Rate - Cancer Network - June 5th, 2021
- Magenta Therapeutics (MGTA) Announces Additional Preliminary Positive Results from Ongoing Phase 2 Clinical Trial of MGTA-145 and Plerixafor in... - June 5th, 2021
- Innovative Regenerative Medicine Therapies Safety Comes First - FDA.gov - June 5th, 2021
- You could be the match: Miracle blood stem cell donor saves young fathers life - WWBT NBC12 News - June 5th, 2021
- Study shows how the physical nature of genome changes before and after cell differentiation - News-Medical.net - June 5th, 2021
- Polatuzumab With Rituximab and Lenalidomide Shown Safe and Effective for Relapsed/Refractory DLBCL - Targeted Oncology - June 5th, 2021
- Lymph nodes: Purpose, location, and disease warning signs - Medical News Today - June 5th, 2021
- Dr. Ghosh on the Role of Off-the-Shelf CAR T-Cell Therapy in Myeloma June - OncLive - June 5th, 2021
- In Some Heavily Pretreated Patients with R/R MM Ide-Cel Continues to Show Deep and Durable Responses - Targeted Oncology - June 5th, 2021
- Fate Therapeutics Highlights Positive Interim Data from its Phase 1 Study of FT516 in Combination with - GlobeNewswire - June 5th, 2021
- High Overall Response Rates Achieved With Cirmtuzumab/Ibrutinib in MCL and CLL - Targeted Oncology - June 5th, 2021
- Stem Cell vs Gene Therapy Processes in SCD - MD Magazine - May 26th, 2021
- Regenerative Medicine Market Size to Reach Revenues of over USD 27 Billion by 2026 - Arizton - PRNewswire - May 26th, 2021
- Meso-Brain project explores 3D printed stem cells to treat neurological conditions - 3D Printing Industry - May 26th, 2021
- Creative Medical Technology Holdings Expands Neurological Application of ImmCelz into Parkinson's Disease - PRNewswire - May 26th, 2021
- Citius Pharmaceuticals Selected to Receive Best Poster Award at the International Society for Cell and Gene Therapy 2021 Annual Meeting - PRNewswire - May 26th, 2021
- Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine | More News | News... - May 26th, 2021
- 3D Printed Stem Cells Could Revolutionize Neuroscience, Aid Treatment and Understanding of Neural Diseases - Science Times - May 26th, 2021
- 'Lion-hearted' ten-year-old Aurora's 'second chance' at life after cancer remission and stem cell transplant - The Isle of Thanet News - May 26th, 2021
- Miami Cancer Institute Achieves 'Summit' With Experts Who Share Advances in Treating Hematologic Malignancies - Baptist Health South Florida - May 26th, 2021
- Jasper Therapeutics Announces New Clinical Trial with the National Institute of Allergy and Infectious Diseases to Evaluate JSP191 in Chronic... - May 26th, 2021
- Autolus Therapeutics Announces an Additional Nature Publication for AUTO1 - GlobeNewswire - May 26th, 2021
- I Peace's cell manufacturing facility "Peace Engine Kyoto" receives third-party certification as US cGMP compliant: the facility now meets... - May 26th, 2021
- New DLBCL Treatments Are Poised to Fill an Unmet Need for Patients in Challenging Settings - OncLive - May 26th, 2021
- Monitoring the potency of cell therapies using bioelectronic assays - Drug Target Review - May 24th, 2021
- Global Cell Therapy Markets, Technologies, and Competitive Landscape Report 2020-2030: Applications, Cardiovascular Disorders, Cancer, Neurological... - May 24th, 2021
- Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19 - BioSpace - May 24th, 2021
- bluebird bio's CALD gene therapy Skysona gains positive opinion from CHMP - PMLiVE - May 24th, 2021
- An Incurable Disease With A Hefty Treatment Cost Motivated Him To Start A Business - Forbes - May 24th, 2021
- Research Highlights from 2021 ACSM Virtual Annual Meeting: Exercise in Regenerative Medicine - Newswise - May 24th, 2021
- Five-year-old boy returns home after first round of cancer treatment in New York - Cambridgeshire Live - May 24th, 2021